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Abstract
Electronic cigarettes (e-cigarettes) 
present a novel method for nicotine 
delivery that is reportedly 
advantageous when compared to 
traditional cigarette usage. 
Manufacturers and consumers claim 
reduced chemical exposure, decreased 
symptom profiles, and efficacy in 
smoking reduction and cessation 
greater than conventional nicotine 
replacement therapies (NRT). 
However these products present new 
challenges and concerns to legislators, 
clinicians, and public health advocates. 
Questions of authority in state and 
federal legislation, establishing 
product quality control, assessing 
long-term studies on e-cigarettes and 
quantifying usefulness in harm 
reduction represent only a portion of 
the many unanswered topics being 
discussed. The purpose of this article is 
to assess the literature on e-cigarettes 
and establish perceptions and attitudes 
on this controversial subject. 
Introduction
Electronic cigarettes (e-cigarettes) 
are a recent addition to the 
marketplace of tobacco products, 
fitting into the broader category 
of electronic nicotine delivery 
systems (ENDS).1,2 First patented 
in the 1960s, manufacture of the 
modern e-cigarette did not begin 
until 2004 when Chinese company 
Ruyan® produced a prototype 
electronic device capable of 
emulating the subjective experience 
of smoking while delivering 
nicotine in the absence of burning 
tobacco.3 They began circulating 
internationally as early as 2007-
2008,3-5 gaining the reputation as 
a safer alternative to conventional 
cigarettes while offering a socially 
acceptable way to mimic smoking 
in smoke-free environments. 
These products are designed to 
resemble their conventional tobacco 
counterparts but deliver nicotine 
through vaporizing a humectant 
carrier, the most common of which is 
propylene glycol, and can be mixed 
with flavorants.3,6-8 Devices consist 
of a disposable nicotine-containing 
cartridge, a heating element, a 
flow trigger, battery, and LED light. 
Nicotine along with the propylene 
glycol humectant and any flavorants 
are drawn from the cartridge towards 
the heating element as the user 
applies suction to the mouthpiece. 
This activates the flow trigger and 
exposes the contents of the cartridge 
to the heating element, vaporizing 
the nicotine solution into a mist that 
is inhaled. The LED light serves as 
an indicator for when the flow trigger 
is open and mimics the burning 
end of a tobacco cigarette. 3,9-12
ENDS sales in the United 
States started as early as 2007,5 
mostly with internet sales. As 
popularity of these devices grew, 
they started appearing in shops 
and mall kiosks, drawing attention 
of state and federal regulators 
who established complicated 
and non-uniform regulations on 
e-cigarettes.6,11-21 While there are 
claims reporting markedly less 
chemical exposure compared to 
tobacco cigarettes and suggesting 
usefulness in smoking cessation 
strategies,3,13,22-31 there remain many 
issues to be addressed: questions 
of legal authority, the absence of 
consistent quality control, long-term 
studies of safety, and usefulness 
in nicotine harm reduction. 
While attitudes towards ENDS 
devices remain mixed, they are a 
quickly evolving source of interest. A 
search of NCBI’s PubMed database 
using the search terms “e-cigarette” 
and “electronic cigarette” yielded 
102 and 495 search results, 
respectively. The literature on the 
subject remains equivocal in many 
respects and subjective data is only 
beginning to be published. What is 
certain about electronic cigarettes 
is that they pose a significant 
area for continued research.
E-Cigarette Culture and 
User Expectations
Electronic cigarettes are marketed 
strongly in television, and movies. 
These products are presented 
as harmless devices that aid in 
smoking cessation and find their way 
onto shows such as ‘The Doctors’ 
and ‘The Late Show with David 
Letterman.’ Advertisers market 
The objectives of this manuscript are to allow the reader to be able to describe e-cigarettes, to be aware of the culture surrounding 
e-cigarettes, to become familiar with the data both positive and negative regarding these products and to review the current 
controversy regarding legislation and regulation.
Objectives
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just as heavily to the celebrities as 
they do to the common consumer, 
going so far as to make e-cigarettes 
gifts at the Grammy Awards.14 
However, unique amongst other 
tobacco products is the presence 
e-cigarettes have on the internet. 
By 2010, Google internet searches 
for ENDS increased dramatically. 
Fifty to seventy five percent of these 
searches in the United States were 
directed towards sites specifically 
dedicated to selling these products15 
and of the top Google search results 
for e-cigarettes, eight of the first ten 
were online distributors.11 Use has 
even found its way onto the world’s 
largest video sharing service, with a 
survey of YouTube videos containing 
e-cigarette users illustrating males 
five times more often as females.32
An entire culture has sprung up 
surrounding the use of e-cigarettes, 
with users self-identifying as “vapors” 
and enthusiastically embracing 
activities related to the use of ENDS 
and in some cases acting as what 
one study referred to as unpaid 
evangelicals.8,33 Internationally, the 
United States has one of the most 
informed populations regarding 
e-cigarettes and those most likely to 
have heard of e-cigarettes are white 
males who are heavy smokers and 
are young, educated, have higher 
income, and have at least one close 
friend who smokes tobacco.5,34-36 Use 
has been reported to mirror similar 
variables34 however other research 
suggests that despite hearing of 
such products less often than their 
well-educated male counterparts, 
female current smokers with less 
than a high school education and 
of lower socioeconomic status are 
more likely to ever have tried an 
e-cigarette.1 Those who try such 
products usually are in their teens 
or twenties but continued use 
correlates with higher educational 
status.5,34,36,37 Non-daily smokers 
are, according to one study,34 twice 
as likely to try e-cigarettes than 
daily smokers and if perceived 
to be less harmful than tobacco 
cigarettes are over four times 
more likely to try ENDS. Non-daily 
smokers make use of e-cigarettes 
more than daily smokers and both 
use them more than those who 
recently ceased tobacco use.34 
Awareness of e-cigarettes is on the 
rise, with a doubling of awareness 
and a quadrupling of ever use 
from 2009 to 20101 but use of 
ENDS products occurs less often 
in the Southwest United States 
compared to other states.37 
Adolescents between the ages of 
11 and 19 have reported awareness 
of e-cigarettes and among those 
individuals eighteen percent have 
expressed a willingness to try them.38 
Use among middle and high school 
students has approximately doubled 
from 2011 to 2012 with about 1.78 
million students in 2012 having ever 
tried an e-cigarette.39,40 Furthermore, 
while older users of e-cigarettes are 
more likely to use these products 
as a means for tobacco cessation, 
college users do not appear to be 
motivated by a desire to quit.41 A 
South Korean study reports that 
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among adolescents, in addition 
to the propensity for males to try 
e-cigarettes reported elsewhere34 
other precipitating factors include 
peer influence, dissatisfaction in 
school life, and a previous history 
of cigarette use.35 This growing 
trend of e-cigarette experimentation 
among minors presents concerns 
of e-cigarettes serving as gateways 
to nicotine addiction.5,38
Users of e-cigarettes cite 
numerous reasons for their 
continued use and most report 
overall satisfaction with their 
devices.42 Chief among these 
is the belief that e-cigarettes 
present a reduced risk of harm 
when compared to tobacco 
cigarettes.3,7,34,36,42 E-cigarettes are 
perceived to decrease tobacco 
cigarette use 3,8,36 and ultimately 
maintain tobacco cessation and 
abstinence in a large number of 
cases.3,7,8,42 The biobehavioral 
feedback mechanisms simulated by 
vaping, the term for smoking an e- 
cigarette, are also cited as reasons 
for e-cigarette use, noting that these 
devices are able to address the oral 
fixation seen in current and former 
smokers, successfully mimicking 
the sensation of smoke against the 
throat (a term called “throat-hit”), 
copying the gestures and actions 
seen in conventional cigarette use, 
and alleviating symptoms of craving 
and withdrawal.3,8,33,42 Numerous 
health benefits are attributed 
to a transition from tobacco to 
e-cigarettes including respiratory 
improvement, decreased cough, 
reduced weight gain after tobacco 
cessation, and increased exercise 
tolerance.3,8 Smokers also highlight 
reductions in loss of smell and taste, 
the avoidance of tobacco odor on 
clothing, and absence of smoker’s 
breath.3,8 Less significant reasons 
are absence of any open flames 
during product use, cheaper overall 
price, avoiding bothering other 
people with cigarette smoke, dealing 
with smoke free situations, and 
serving as a complete alternative 
to smoking.3,7,42 Not all reasons 
cited for the use of ENDS products 
are a reduction in negative effects 
of tobacco products. Many users 
reported positive aspects of ENDS 
usage including social benefits 
through a sense of belonging to an 
online vaping community, hobby 
elements as users purchase and 
customize their e-cigarettes, and 
establishing a sense of personal 
identity in calling themselves 
vapers.15,33 Many e-cigarette users 
enjoy modifying (or “modding”) 
their products to include larger 
batteries for fewer charges between 
uses or to sustain larger amounts 
of vapor for larger throat hits.8
While users are quick to point out 
that these devices can help achieve 
a successful nicotine taper, they 
are firm in drawing the distinction 
between smoking cessation and 
nicotine cessation. Eliminating the 
harmful effects of cigarettes while 
still maintaining the ‘good’ effects 
of nicotine is seen by users as a 
desirable outcome.33 Although similar 
to the goals of conventional nicotine 
replacement therapies (NRT) and 
in many instances used similarly by 
former smokers to avoid relapses 
or to bolster smoking cessation,42 
users of ENDS report a stronger 
preference to the e-cigarette with 
fewer reported side effects.7,8,33,42  
Positive Data Findings on 
E-Cigarettes
Although there is relatively little 
data to objectively lend credibility 
to assertions of harm reduction, 
the data available does show 
promise. Whereas up to 80% of 
individuals who use conventional 
NRT for smoking cessation return to 
smoking by one year,9 e-cigarettes 
may help reduce the number 
of cigarettes smoked, maintain 
abstinence at six months after initial 
purchase, and reduce dependence 
on nicotine.22 While some studies 
report only modest improvements, 
likening their use to nicotine 
patches23 smokeless tobacco 
including e-cigarettes is reported 
to be 90-99% less deadly than 
tobacco cigarettes18 and effective 
at delivering nicotine into the blood, 
decreasing withdrawal symptoms 
associated with smoking cessation.24 
E-cigarettes may decrease tobacco 
cigarette consumption in those who 
have no intention to quit smoking 
while maintaining a reduced side 
effect profile compared to tobacco 
cigarettes.1,3,25-31 Interestingly, 
the abstinence induced by these 
products seems to be irrespective 
of nicotine concentration25 once 
again strengthening the possible 
explanation that this is due to the 
biobehavioral feedback mechanisms 
mimicked in e-cigarettes compared 
to other forms of NRT.3,31 
Furthermore, e-cigarettes have 
been effective in treating patients 
who are refractory to all other 
forms of tobacco cessation.43 
Public health has also seen 
improvements with e-cigarettes. 
In Sweden the introduction of 
smokeless tobacco products 
including e-cigarettes has greatly 
decreased smoking related 
fatalities.13 American studies also 
report the public health benefits of 
e-cigarettes as a harm reduction 
strategy compared to traditional 
tobacco cigarette usage.3,4,31,44 
These series of studies admit it may 
be premature to make sweeping 
conclusions, but they feel that there 
are no serious health concerns when 
compared to traditional cigarette use 
due to drastic reductions in harmful 
toxicants by an order of anywhere 
from 9-450%.44 Analyses of 
e-cigarette vapor yielded reductions 
in nicotine, carbon monoxide, 
tobacco specific nitrosamines (TSN) 
including N’-nitrosonornicotine 
(NNN), N’nitrosoanatabine (NAT), 
N’nitrosanabasine (NAB), and 
4-(methylnitrosamino-1-(3-pyridyl)-
1-butanone (NNK), carbonyl 
compounds including formaldehyde, 
acetaldehyde, acrolein, and 
o-methylbenzaldehyde, volatile 
organic compounds such as toluene 
and pim-xyline, the metals cadmium, 
nickel, and lead, and polyaromatic 
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hydrocarbons.44,45 When compared 
to the emissions found in tobacco 
cigarettes, authors of these 
articles claim these levels pose no 
apparent risk to human health.45 
Negative Data Findings on 
E-Cigarettes
While there may be benefits to 
e-cigarette usage, there are still 
drawbacks and consequences. 
Currently e-cigarettes lack regulation 
of manufacture, enforcement of 
sanitary conditions, guidelines in 
handling pharmaceutical-grade 
ingredients, and incomplete or 
absent listing of constituents.3 The 
most egregious of these offenses 
is the lack of quality control, with 
brands having wildly different 
concentrations of nicotine.46,47 
Products listed as having no nicotine 
reveal significant concentrations 
upon analysis.3,6,48 There are even 
products claiming to possess 
E-Cialis (tadalafil) and rimonobant 
for erectile dysfunction and dieting, 
respectively, without ever assessing 
the validity or safety of such 
claims.48 Among the chemicals 
known to be present in e-cigarettes, 
propylene glycol presents possible 
carcinogenic concerns 6 and initial 
exposure causes sore throat, dry 
cough, and dizziness.3,49 Other 
humectants such as glycerin and 
diethylene glycol, not advertised 
as present in e-cigarettes, are also 
found and present health concerns 
in poorly quality controlled settings,6 
however the FDA reports that in the 
measurements it has made on a 
limited number of products it has not 
found lethal concentrations of these 
substances.3 Other miscellaneous 
irritants including butyl acetate, 
diethyl carbonate, benzoic acid, 
quinolone, dioctyl phthalate, and 
2,6-dimethyl phenol were also 
found as unlisted ingredients but 
have unclear significance.6 “Passive 
vaping,” a form of second-hand 
smoke for e-cigarettes, has also 
been confirmed however it too 
is in early stages of study.50
Additional product concerns 
include fluid leaks from cartridges, 
difficulties assembling apparatuses 
without spilling nicotine fluid, poor 
labeling, poor or absent instruction 
on how to properly dispose of spent 
cartridges, failed safety features, 
baseless claims, and errors in 
filling orders.6,10 Furthermore, 
whereas traditional cigarettes 
have only 1-2 mg of nicotine each, 
nicotine cartridges carry far greater 
concentrations. With lethal doses 
of nicotine anywhere from 30-60 
mg, there is concern that children or 
even adults may accidentally expose 
Schematic of Average Electronic Cigarette The average e-cigarette contains six essential parts: first, a heating unit vaporizes 
nicotine-containing humectant responsible for the formation of the aerosolized nicotine and optional flavorants. It is controlled by a 
sensor and microprocessor which are involved in detecting the suction applied by the user and regulating the heating of the humectant. 
The solution is contained in a disposable or refillable cartridge and a battery source provides the necessary energy for aerosolizing the 
fluid. Lastly, an LED light is often placed at the end of the device to simulate the visual queue of a cigarette burning during suction and 
to notify others that the device is in use. 
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themselves to fatal overdoses if not 
properly handling their devices.6,17,51 
Of concern is the use of 
e-cigarettes among children and 
populations heretofore abstinent 
from nicotine products. Companies 
have been known to distribute free 
samples9 and there are concerns 
that these will encourage novices 
to become addicted to what they 
perceive as a safer smoking 
product.4 Children are targeted 
for addiction with the addition of 
flavorants including strawberry and 
chocolate to mask the otherwise 
bitter taste of the product.6,38-40
Legislation
Currently e-cigarettes are in a 
state of legal ambiguity. The FDA 
met resistance from the DC Circuit 
Court in the 2011 case Sottera Inc. 
v. FDA, in which the court ruled that 
e-cigarette regulation at the federal 
level is outlined according to the 
2009 Family Smoking Prevention 
and Tobacco Control Act and not the 
Federal Food, Drug, and Cosmetic 
Act (FDCA). While the FDA 
attempted to regulate and control 
the sale of e-cigarettes, claiming 
they were in fact misbranded 
drug device combinations and 
thus deserving of regulation as 
medical devices, Sottera Inc. 
successfully appealed that the 
FDA can only regulate tobacco 
products marketed as therapeutic. 
In so doing, the court prohibited 
the FDA’s ability to effectively 
regulate these devices, drastically 
hindering any efforts to ensure 
quality control or safety.11,12,16,19  It 
took three years to overcome this 
setback, but, in April 2014, the 
FDA proposed a rule to extend 
their authority to include regulation 
of additional tobacco products 
including e-cigarettes. Importantly, 
the new rule would allow the FDA 
to prohibit free samples, limit the 
sale of the products to adults, and 
limit any health claims to those 
supported by scientific evidence.52
States have been able to take 
local action to regulate the sale and 
use of e-cigarettes to a degree, 
mirroring laws in place for traditional 
tobacco products. California, Utah, 
and New Jersey do not allow the 
sale of ENDS to minors and Oregon 
does not sell ENDS at all. New 
Jersey and New York ban the sale 
and public use of the devices.11 
The United States Air Force bans 
the devices on their premises.14 
Conclusion
Presently there is a scarcity 
of trials with long term follow 
up of e-cigarette use 3 and an 
absence of nonclinical, animal, 
clinical, and public health studies 
to draw sufficient conclusions 
to make definitive statements.52 
Until these studies are performed, 
clinicians should advise patients 
that there is not enough evidence 
to definitively say that these 
products are safe or effective to 
use for smoking cessation.2 
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CME Post-Test
1.  Awareness of e-cigarettes in the US 
quadrupled from 2009-2010
 True False
2.  Forty to fiffty-five percent of Google searches for 
e-cigarettes are for sites selling the devices
  True False
3.  Use among middle school and high school students 
ever trying e-cigarettes doubled from 2011-2012
 True False
Invitation for Submissions  to
a Vignette Series
Compassion in Medicine
The West Virginia Medical Journal (WVMJ) is solicit-
ing vignettes from West Virginia physicians, who have 
practiced in the state for at least 10 years. Vignettes 
should highlight experiences in which their patient care 
inspired or educated the author in a meaningful way.
Submissions are limited to 700 words. Please accom-
pany your submission with a cover letter, including your 
name, address, email address, title and employment af-
filiation and years in practice. Submissions are open to 
all West  Virginia physicians.
Vignettes will be published periodically throughout the 
year, without specific notice of a scheduled publica-
tion date. Please be sure the submission contains no 
identifiable patient information. Only one submission 
per author.
